InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
20%
T+90 mean return
-14.0%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by BRINTNALL JOHN, Directeur Stratégique. Insider active across 1 company, notably CVRx, Inc.. Cumulatively, 5 reports have been recorded. History available since 30 December 2021. The latest transaction was filed on 22 April 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations5 total
1,590 shares@ US$0.2370.0002% mcap24.6% of flowCommon StockSEC:0001415889-22-004253:0
2,550 shares@ US$0.23737.7% of flowCommon StockSEC:0001179110-22-000007
2,550 shares@ US$0.2370.0003% mcap37.7% of flowCommon StockSEC:0001179110-22-000007:0
2,242 sharesCommon StockSEC:0001179110-21-007342
2,242 sharesCommon StockSEC:0001179110-21-007342:0
5 of 5 declarations
About BRINTNALL JOHN
John Brintnall serves as Chief Strategy Officer and Secretary at CVRx, Inc. He is responsible for formulating and executing the company's strategy. CVRx is a medical technology company developing innovative solutions to treat hypertension. Mr. Brintnall's expertise in the healthcare sector allows him to contribute to the strategic direction of the company.
